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ABSTRACT
Since the maintenance of the appropriate levels of oxygen is essential for ensuring the suc-
cess of many of the specialized experiments in space missions, such as tissue culture experi-
ments, the continuous monitoring of partial pressures of oxygen provides important data.   We are
developing optical methods of monitoring not only oxygen but also many dissolved constituents in
blood and tissue culture solutions.  The optical system uses tiny optical fibers, which easily fit
inside a fine-gauged needle, for monitoring each specimen.  Moreover, the beam can be split so
that multiple specimens can be monitored simultaneously.  The same optical technology can also
be used for monitoring the blood chemistry of humans and animals; it is minimally invasive.  It has
a medical application for measuring tissue partial pressures of oxygen.
INTRODUCTION
The shuttle have been used for a variety of scientific experiments in the biological and medical
sciences.  Oxygen is essential for survival of aerobic (oxygen-utilizing) organisms.  Low or el-
evated oxygen partial pressures can derange metabolism and cause cellular injury.  For ground-
based experiments, oxygen electrodes are available are available.  Though they have limitations
for continuous, long-term monitoring, they are accurate and widely used, for example, in medicine
(operating rooms) and for environmental studies.  Thus, maintaining oxygen partial pressures
within a narrow optimal range is essential for conducting successful experiments.  However, in
spacecraft where size and weight are extremely limited and the time of the astronauts is divided
among multiple experiments, it has not been feasible to monitor oxygen continuously with current
methods.  Instead, periodic measurements or estimates usually substitute for intermittent or con-
tinuous analyses.  Thus, the development of reliable automated analyses would improve the envi-
ronmental control of tissue culture and other experiments and also reduce the ambiguity that has
plagued the interpretation of the results of many experiments.
Optical sensors offer an advantage for routine tests that are frequently performed for extended
periods of time on space missions, such as monitoring oxygen partial pressures (pO2).
BACKGROUND OF PROBLEM
Our interest in monitoring tissue oxygen partial pressures (pO2) began when we started a
project relating to the treatment of late radiation tissue injury (LRTI).  LRTI, a form of radionecrosis,
occurs in up to 5% of cancer patients treated with high dose curative intent radiation therapy.  A
frequent manifestation of LRTI is the occurrence of a hypoxic non-healing wound about 3 months
later, for which hyperbaric oxygen therapy (HBOT) has become well established as the principal
therapy (Mader, 1989).  The primary benefit of HBOT in LRTI related wounds appears to be the
establishment or a suitably steep gradient at the interface between normal tissue and LRTI, pro-
moting angiogensis (formation of capillaries, veins, arteries) via macrophage mediated growth
factors (Baffour et al., 1992; Knighton et al., 1981; Marx et al., 1990, 1995; Schweiki et al., 1992).
For treatment of radionecrosis, Marx (1995) found that a 20 exposure therapy greatly enhanced
the chances (90%) of complete wound healing.
Hyperbaric oxygen therapy has been employed for treating a number of different medical con-
ditions besides wound healing.  For example, surgery for certain forms of congenital heart disease
is sometimes carried out in high-pressure tanks (Ganong, 1995; pg. 635).  Hyperbaric oxygen has
also been used to treat gas gangrene (pO2 > 70 mm Hg stops the growth of clostridial organisms),
carbon monoxide and cyanide poisoning (Guyton, 1991; pg. 475).  However, because of the risk of
oxygen toxicity, the patient’s exposure to hyperbaric oxygen must be carefully monitored to con-
form to time and pressure schedules.  These schedules are medically conservative and provide
guidelines for exposure times to protect patients against developing overt symptoms of oxygen
toxicity.  Nonetheless, these methods are indirect and are based on behavioral or other manifesta-
tions rather than on direct real-time measurement of tissue pO2.
Although an oxygen electrode can be inserted into the artery for periodic measurements dur-
ing surgery, there is no device for hyperbaric conditions that provides continuous real-time moni-
toring of oxygen direct that is the counterpart to pulse oximetry and transcutaneous oximetry (see
below).  Moreover,  there are no routine methods for the continuous monitoring of blood and tissue
pO2 during exposure to hyperbaric oxygen.  Thus, our goal was to develop a method of measuring
tissue pO2 directly.
Current Clinical Methods
Table 1 summarizes the types of sensors for measuring oxygen.  Details of the uses of oxygen
electrodes, pulse oximetry, and transcutaneous oximetry are described below.
Table 1.  Types of sensors for measuring oxygen partial pressures that are currently used
clinically
Oxygen Electrodes
The Clark electrode is the most commonly used (Clark, 1956) and established method for
measuring concentrations of oxygen in arterial and venous blood.  In critical care settings, intra-
vascular sensors are inserted into a catheter for analyzing blood pH, pCO2, pO2.  Intravasulcar
sites pose the hazard of blood clot formation and infections.  On the other hand, tissues do not
provide representative monitoring sites, since concentrations vary between parts of the body (Alcock
and Turner, 1994).  Moreover, because it consumes oxygen, the oxygen electrode cannot be used
for determining oxygen concentrations in poorly vascularized whole tissues or in cells.
Pulse Oximetry
Pulse oximeters are commonly used in surgery and in intensive care units for measuring (es-
timating) arterial hemoglobin-oxygen saturation continuously and non-invasively.  Pulse oximeters
determine the pulsatile variations in optical density of tissues in the red and infrared wavelengths
to compute arterial oxygen saturation without calibration (Alcock and Tuner, 1994). Pulse oximetry
instruments assume that the forward scattered plethymographic pulsatile signals are due to arte-
rial blood. In fact, blood pressure and flow remain pulsatile in microcirculation, which allow the
noninvasive measure of arterial saturation from the finger tip or the ear lobe (Takatani and Ling,
1994).
Pulse oximetry is limited in applications sites of transmission. This device, however, does not
provide an accurate representation of organ tissue oxygenation, in particular, the brain (Li et al.,
1990).  There are marked regional differences because of flow patterns controlled because of
dilation or constriction of vessels by the sympathetic nervous system.
Transcutaneous Oximetry
Transcutaneous oximetry uses a Clark-type electrically heated oxygen-sensing electrodes that
are attached to the skin (Rooke, 1992).  The electrode attaches to the skin with double-sided
adhesive tape.  An electric heating element, which is built into the electrode, controls local skin
temperature.  The heating element is warmed to 43-45C which minimizes local vasomotor tone
and causes nearly maximal vasodilation of the underlying cutaneous vasculature.  Transcutane-
ous oxygen tension serves as an index of the adequacy of skin blood flow, and therefore yields
valuable “functional” information not provided by noninvasive “anatomical” testing modalities such
as echo-doppler ultrasound imaging.
Transcutaneous oximetry measures cutaneous oxygen tensions (TcPO2) from the outside of
the skin.  In brief, oxygen in the blood diffuses out of the cutaneous capillaries into the interstitial
spaces and surrounding skin cells.  Although some of this oxygen is used for skin cellular metabo-
lism, the remainder diffuses throughout the skin, which in turn is responsible for cutaneous oxygen
tension.
Transcutaneous oxygen measurements provide good reproducibility and detect relatively small
changes in TcPO2 produced by disease progression or therapeutic intervention, such as in people
with longstanding diabetes because of the high incidence of vascular degeneration the extremities
(Hauser et al., 1984).
NEW DEVELOPMENTS AND THEIR USES: THERAPEUTIC AND SPACE MISSIONS
The use of fiber optics for measuring oxygen is not new (Wolthuis, 1994).  We are proposing
an improved methodology that is adaptable to more medical and research needs (Ham and Cohen,
1996).  The sensor is based on the principle of reflection or backward scattered optical spectros-
copy.  The concept of the prototype pO2 sensor (shown in Fig. 1) uses multi-mode optical fibers in
a bundle to allow a remote scenario for the sensor.  That is, all of the instrumentation electronics
would be located external to the test chamber (i.e., remote processing), and the only portion of the
sensor system that would be inside of the chamber are the optical fibers.  Details of the needle
sensor are shown in Fig. 2.  Of importance in this type of pO2 sensor is the wavelength dependent
absorption properties of various species such as hemoglobin and cytochrome contained in tissue
samples which will affect the measured transmittance and reflectance (Takatani and Ling, 1994).
The optical fiber approach allows tremendous flexibility in carrying out experiments because it
reduces limitations of the particular configuration of the samples to be tested.  Also, an optical fiber
approach would be necessary if this concept was taken to the level of use in a hyperbaric cham-
ber.  The main design criterion for this type of sensor would be nonflammability because of the
oxygen levels in the hyperbaric chamber where the sensor would be used.  Discrimination of the
net tissue oxygen saturation levels will be carried out using a Partial Least-Squares (PLS) (Ham
and Kostanic, 1996; Marten and Naes, 1989) statistical calibration modeling approach.
Therapeutic. There is currently no simple method to quantitate directly interstitial/cellular pO2 for
diagnostic or therapeutic purposes in an HBO environment.  If such a method is developed, the
therapeutic benefit of HBOT for LRTI could be more reliably predicted and documented. Since the
O2 metabolic effect on angiogenesis occurs within the interstitial compartment and lags the alveo-
lar and arterial pO2 (Well et al., 1977), the objective assessment of LRTI related wounds (Marx,
1995) requires a direct method of quantitating interstitial/cellular pO2.
However, HBOT also poses health and safety hazards (Mader,1989; Sheffield and Dunn, 1997).
For these reasons, the development of a method for monitoring of the O2 gradient would signifi-
cantly improve the therapeutic potential and safety of HBOT:  1) quickly and accurately establish-
ing the appropriate O2 gradient between the normal and the wounded hypoxic tissue and 2) main-
taining the O2 gradient for a therapeutically appropriate length of time.
Space Missions.  Because of the shortage of space and limitations of energy consumption, a
greater number biological and medical experiments are employing tissue culture in its various
forms.  In tissue culture, cells are maintained in an artificial medium that approximates body fluids
or blood serum (blood without the cells and clotting factors).  The maintenance conditions are
critical for the success of the experiments.  Although cells sometimes display a physiological lati-
tude for survival under suboptimal conditions, they will often shutdown nonessential functions
during conditions of stress or synthesize stress substances to help them survive.  During the
conditions of stress, the ability of the cells to respond normally to the test substances is compro-
mised or eliminated.  The inability to maintain optimal conditions is largely responsible for the
ambiguous results and failed experiments that have plagued many biological and medical experi-
ments.  The small size of the fiber optics will allow continuous monitoring of multiple tissue culture
systems (Fig. 2).  The fiber optics can be connected to a feedback loop to increase/decrease
oxygen partial pressures as needed or sound an alarm to alert the astronaut to correct the prob-
lem.
Figure 1.  (a)  Concept of the prototype pO2 sensor for interstitial measurements in hyperbaric
oxygen therapy.  The sensor is based on the principle of reflection or backward scattered optic
spectroscopy.  (b)  Bottom view of the needle sensor tip showing the optical fiber bundle with the
center fiber (and micro-lens for focusing) for the light source.  The other optical fibers in the bundle,
along with the larger micro-lens, are used to collect the backscattered light.  (c)  Side view of the
needle sensor tip.
Figure 2.  Optical fiber bundles can be inserted into multiple tissue culture specimens for monitor-
ing oxygen partial pressures.  The multiple monitoring of oxygen will automate this process.
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